(Q36755742)

English

Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article

scientific article published on 22 October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1 reference

based on heuristic

inferred from title

blood–brain barrier

1 reference

based on heuristic

inferred from title

16

object named as

Howard A Riina

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

10

object named as

Philip Stieg

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

12

object named as

Jared Knopman

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Apostolos Tsiouris

2

object named as

Apostolos J Tsiouris

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

author name string

John A Boockvar

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Christoph P Hofstetter

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Ilhami Kovanlikaya

4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Sherese Fralin

5

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Kartik Kesavabhotla

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Stephen M Seedial

7

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Susan C Pannullo

8

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Theodore H Schwartz

9

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Robert D Zimmerman

11

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Ronald J Scheff

13

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Paul Christos

14

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Shankar Vallabhajosula

15

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

22 October 2010

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Journal of Neurosurgery

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

114

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

624-632

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Balloon-assisted superselective intra-arterial cerebral infusion of bevacizumab for malignant brainstem glioma. A technical note

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

29 September 2017

Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

29 September 2017

Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

29 September 2017

Experience with irinotecan for the treatment of malignant glioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

29 September 2017

Neurosurgery: chemotherapy in conjunction with blood-brain barrier modification in patients with cerebral metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

29 September 2017

Safety and efficacy of adjunctive balloon remodeling during endovascular treatment of intracranial aneurysms: a literature review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

29 September 2017

Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

29 September 2017

Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

28 June 2018

Cerebrovascular Biology and the various neural barriers: challenges and future directions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

28 June 2018

Intra-arterial Cereport (RMP-7) and carboplatin: a dose escalation study for recurrent malignant gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

28 June 2018

Blood-brain barrier disruption in immature Fischer 344 rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

28 June 2018

Comparison of intravenous versus intracarotid therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea in a rat brain tumor model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

28 June 2018

Osmotic blood-brain barrier modification: monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

28 June 2018

Permeability of human brain tumor to 99mTc-gluco-heptonate and 99mTc-albumin. Implications for monoclonal antibody therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

28 June 2018

Osmotic blood-brain barrier opening to IgM monoclonal antibody in the rat.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

28 June 2018

Pharmacokinetics of superselective intra-arterial and intravenous [11C]BCNU evaluated by PET.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

28 June 2018

Chemotherapy administered in conjunction with osmotic blood-brain barrier modification in patients with brain metastases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

28 June 2018

Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

28 June 2018

Intra-arterial ACNU Chemotherapy Employing 20% Mannitol Osmotic Blood-brain Barrier Disruption for Malignant Brain Tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

28 June 2018

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

5 September 2018

Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

5 September 2018

Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

5 September 2018

Bevacizumab--news from the fast lane?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

5 September 2018

Bevacizumab in recurrent malignant glioma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

5 September 2018

18F-FDG PET of common enhancing malignant brain tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

5 September 2018

Expression of VEGF and its receptor genes in intracranial schwannomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

5 September 2018

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

5 September 2018

Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

5 September 2018

Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain-barrier disruption

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

5 September 2018

Imaging changes and cognitive outcome in primary CNS lymphoma after enhanced chemotherapy delivery.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

5 September 2018

Intra-arterial carboplatin chemotherapy for brain tumors: a dose escalation study based on cerebral blood flow.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

5 September 2018

Intra-arterial mannitol infusion in the chemotherapy for malignant brain tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

5 September 2018

Effect of blood-brain barrier disruption on intact and fragmented monoclonal antibody localization in intracerebral lung carcinoma xenografts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

5 September 2018

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3622705

5 September 2018

Intra-arterial ACNU and cisplatin chemotherapy for the treatment of glioblastoma multiforme

1 reference

https://pubmed.ncbi.nlm.nih.gov/20964595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacology of intraarterial cis-diamminedichloroplatinum(II)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20964595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of the brain areas perfused by superselective intra-arterial chemotherapy using single photon emission computed tomography with technetium-99m-hexamethyl-propyleneamine oxime--technical note

1 reference

https://pubmed.ncbi.nlm.nih.gov/20964595

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3171/2010.9.JNS101223

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36755742&oldid=1640539726"